Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Perspective Therapeutics Inc CATX

Healthcare Biotechnology
Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is developing advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. It is also developing imaging diagnostics that... see more

Recent & Breaking News (NYSEAM:CATX)

IsoRay, Inc. Reports First Quarter Results

Marketwired November 15, 2013

Johns Hopkins and Rutgers Medical School Now Utilizing IsoRay's Cesium-131 Sutured Seeds in Treating Metastatic Brain Cancer

Marketwired October 21, 2013

IsoRay's Cancer Fighting Cesium-131 Seeds, Sutures and Seeded Mesh Receive High Marks With Six Abstracts Presented During (ASTRO) the American Society for Radiation Oncology Conference

Marketwired October 14, 2013

IsoRay, Inc. Reports Fiscal Year 2013 Results

Marketwired September 30, 2013

IsoRay, Inc. Announces Re-Pricing of Underwritten Offering

Marketwired August 29, 2013

IsoRay, Inc. Announces Underwritten Offering

Marketwired August 28, 2013

IsoRay's Cesium-131 Cancer Treatment Products and Results Will Be Discussed in a Number of Papers Presented During the American Society for Radiation Oncology Convention (ASTRO)

Marketwired August 13, 2013

IsoRay Announces World's First Cesium-131 Seeded Mesh Treatment for Advanced Rectal Cancer

Accesswire July 8, 2013

IsoRay Announces a New International Distributor in Australia and New Zealand

Marketwired June 25, 2013

IsoRay Announces A New International Distributor For Greece

PR Newswire May 21, 2013

IsoRay, Inc. Reports Third Quarter Results

Marketwired May 15, 2013

IsoRay on Display at the American Brachytherapy Society (ABS) Convention Featuring Its Cesium-131 Cancer Fighting Portfolio

Marketwired April 15, 2013

IsoRay, Inc. States Its Policy Not to Comment on Unusual Market Activity

PR Newswire February 27, 2013

First International Brain Cancer Treatments Performed Utilizing IsoRay's GliaSite Radiation Therapy System

Marketwired February 21, 2013

IsoRay, Inc. Reports Second Quarter Results

Marketwired February 14, 2013

Metastatic Brain Cancer Video Released by Cornell Weill

PR Newswire February 5, 2013